Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Join SI Premium – FREE
Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Navan, Inc. (NAVN) Tops Q2 EPS by 1c, Offers Guidance
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
